GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Operating Margin %

Ibex Technologies (TSXV:IBT) Operating Margin % : 8.17% (As of Jan. 2024)


View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Ibex Technologies's Operating Income for the three months ended in Jan. 2024 was C$0.16 Mil. Ibex Technologies's Revenue for the three months ended in Jan. 2024 was C$1.92 Mil. Therefore, Ibex Technologies's Operating Margin % for the quarter that ended in Jan. 2024 was 8.17%.

The historical rank and industry rank for Ibex Technologies's Operating Margin % or its related term are showing as below:

TSXV:IBT' s Operating Margin % Range Over the Past 10 Years
Min: -23.47   Med: 7.62   Max: 29.87
Current: 24.08


TSXV:IBT's Operating Margin % is ranked better than
92.27% of 1022 companies
in the Biotechnology industry
Industry Median: -154.335 vs TSXV:IBT: 24.08

Ibex Technologies's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Ibex Technologies's Operating Income for the three months ended in Jan. 2024 was C$0.16 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jan. 2024 was C$1.93 Mil.


Ibex Technologies Operating Margin % Historical Data

The historical data trend for Ibex Technologies's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Operating Margin % Chart

Ibex Technologies Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.47 14.26 16.11 29.87 24.67

Ibex Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.26 28.75 29.08 29.54 8.17

Competitive Comparison of Ibex Technologies's Operating Margin %

For the Biotechnology subindustry, Ibex Technologies's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibex Technologies's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's Operating Margin % falls into.



Ibex Technologies Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Ibex Technologies's Operating Margin % for the fiscal year that ended in Jul. 2023 is calculated as

Operating Margin %=Operating Income (A: Jul. 2023 ) / Revenue (A: Jul. 2023 )
=1.848 / 7.492
=24.67 %

Ibex Technologies's Operating Margin % for the quarter that ended in Jan. 2024 is calculated as

Operating Margin %=Operating Income (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=0.157 / 1.922
=8.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ibex Technologies  (TSXV:IBT) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Ibex Technologies Operating Margin % Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibex Technologies (TSXV:IBT) Business Description

Traded in Other Exchanges
Address
5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines